Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Immuno-oncology Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-oncology Therapy Market Perspective (2018-2029)
2.2 Global Immuno-oncology Therapy Growth Trends by Region
2.2.1 Immuno-oncology Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immuno-oncology Therapy Historic Market Size by Region (2018-2024)
2.2.3 Immuno-oncology Therapy Forecasted Market Size by Region (2024-2029)
2.3 Immuno-oncology Therapy Market Dynamics
2.3.1 Immuno-oncology Therapy Industry Trends
2.3.2 Immuno-oncology Therapy Market Drivers
2.3.3 Immuno-oncology Therapy Market Challenges
2.3.4 Immuno-oncology Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immuno-oncology Therapy by Players
3.1.1 Global Immuno-oncology Therapy Revenue by Players (2018-2024)
3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immuno-oncology Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Immuno-oncology Therapy Market Concentration Ratio
3.4.1 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Therapy Revenue in 2022
3.5 Global Key Players of Immuno-oncology Therapy Head office and Area Served
3.6 Global Key Players of Immuno-oncology Therapy, Product and Application
3.7 Global Key Players of Immuno-oncology Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-oncology Therapy Breakdown Data by Type
4.1 Global Immuno-oncology Therapy Historic Market Size by Type (2018-2024)
4.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029)
5 Immuno-oncology Therapy Breakdown Data by Application
5.1 Global Immuno-oncology Therapy Historic Market Size by Application (2018-2024)
5.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immuno-oncology Therapy Market Size (2018-2029)
6.2 North America Immuno-oncology Therapy Market Size by Type
6.2.1 North America Immuno-oncology Therapy Market Size by Type (2018-2024)
6.2.2 North America Immuno-oncology Therapy Market Size by Type (2024-2029)
6.2.3 North America Immuno-oncology Therapy Market Share by Type (2018-2029)
6.3 North America Immuno-oncology Therapy Market Size by Application
6.3.1 North America Immuno-oncology Therapy Market Size by Application (2018-2024)
6.3.2 North America Immuno-oncology Therapy Market Size by Application (2024-2029)
6.3.3 North America Immuno-oncology Therapy Market Share by Application (2018-2029)
6.4 North America Immuno-oncology Therapy Market Size by Country
6.4.1 North America Immuno-oncology Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Immuno-oncology Therapy Market Size by Country (2018-2024)
6.4.3 North America Immuno-oncology Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Immuno-oncology Therapy Market Size (2018-2029)
7.2 Europe Immuno-oncology Therapy Market Size by Type
7.2.1 Europe Immuno-oncology Therapy Market Size by Type (2018-2024)
7.2.2 Europe Immuno-oncology Therapy Market Size by Type (2024-2029)
7.2.3 Europe Immuno-oncology Therapy Market Share by Type (2018-2029)
7.3 Europe Immuno-oncology Therapy Market Size by Application
7.3.1 Europe Immuno-oncology Therapy Market Size by Application (2018-2024)
7.3.2 Europe Immuno-oncology Therapy Market Size by Application (2024-2029)
7.3.3 Europe Immuno-oncology Therapy Market Share by Application (2018-2029)
7.4 Europe Immuno-oncology Therapy Market Size by Country
7.4.1 Europe Immuno-oncology Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Immuno-oncology Therapy Market Size by Country (2018-2024)
7.4.3 Europe Immuno-oncology Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immuno-oncology Therapy Market Size (2018-2029)
8.2 China Immuno-oncology Therapy Market Size by Type
8.2.1 China Immuno-oncology Therapy Market Size by Type (2018-2024)
8.2.2 China Immuno-oncology Therapy Market Size by Type (2024-2029)
8.2.3 China Immuno-oncology Therapy Market Share by Type (2018-2029)
8.3 China Immuno-oncology Therapy Market Size by Application
8.3.1 China Immuno-oncology Therapy Market Size by Application (2018-2024)
8.3.2 China Immuno-oncology Therapy Market Size by Application (2024-2029)
8.3.3 China Immuno-oncology Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Immuno-oncology Therapy Market Size (2018-2029)
9.2 Asia Immuno-oncology Therapy Market Size by Type
9.2.1 Asia Immuno-oncology Therapy Market Size by Type (2018-2024)
9.2.2 Asia Immuno-oncology Therapy Market Size by Type (2024-2029)
9.2.3 Asia Immuno-oncology Therapy Market Share by Type (2018-2029)
9.3 Asia Immuno-oncology Therapy Market Size by Application
9.3.1 Asia Immuno-oncology Therapy Market Size by Application (2018-2024)
9.3.2 Asia Immuno-oncology Therapy Market Size by Application (2024-2029)
9.3.3 Asia Immuno-oncology Therapy Market Share by Application (2018-2029)
9.4 Asia Immuno-oncology Therapy Market Size by Region
9.4.1 Asia Immuno-oncology Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Immuno-oncology Therapy Market Size by Region (2018-2024)
9.4.3 Asia Immuno-oncology Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-oncology Therapy Introduction
11.1.4 Amgen Revenue in Immuno-oncology Therapy Business (2018-2024)
11.1.5 Amgen Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-oncology Therapy Introduction
11.2.4 AstraZeneca Revenue in Immuno-oncology Therapy Business (2018-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-oncology Therapy Introduction
11.4.4 Eli-Lilly Revenue in Immuno-oncology Therapy Business (2018-2024)
11.4.5 Eli-Lilly Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-oncology Therapy Introduction
11.5.4 Roche Revenue in Immuno-oncology Therapy Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-oncology Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2018-2024)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-oncology Therapy Introduction
11.7.4 Janssen Biotech Revenue in Immuno-oncology Therapy Business (2018-2024)
11.7.5 Janssen Biotech Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-oncology Therapy Introduction
11.8.4 Merck Revenue in Immuno-oncology Therapy Business (2018-2024)
11.8.5 Merck Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-oncology Therapy Introduction
11.9.4 Novartis Revenue in Immuno-oncology Therapy Business (2018-2024)
11.9.5 Novartis Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-oncology Therapy Introduction
11.10.4 Pfizer Revenue in Immuno-oncology Therapy Business (2018-2024)
11.10.5 Pfizer Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-oncology Therapy Introduction
11.11.4 Sanofi Revenue in Immuno-oncology Therapy Business (2018-2024)
11.11.5 Sanofi Recent Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Details
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2018-2024)
11.12.5 Spectrum Pharmaceuticals Recent Developments
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-oncology Therapy Introduction
11.13.4 Takeda Revenue in Immuno-oncology Therapy Business (2018-2024)
11.13.5 Takeda Recent Developments
11.14 BioNTech SE
11.14.1 BioNTech SE Company Details
11.14.2 BioNTech SE Business Overview
11.14.3 BioNTech SE Immuno-oncology Therapy Introduction
11.14.4 BioNTech SE Revenue in Immuno-oncology Therapy Business (2018-2024)
11.14.5 BioNTech SE Recent Developments
11.15 Allogene Therapeutics
11.15.1 Allogene Therapeutics Company Details
11.15.2 Allogene Therapeutics Business Overview
11.15.3 Allogene Therapeutics Immuno-oncology Therapy Introduction
11.15.4 Allogene Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024)
11.15.5 Allogene Therapeutics Recent Developments
11.16 IMAB-I-Mab Biopharma Co., Ltd.
11.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Details
11.16.2 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
11.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Introduction
11.16.4 IMAB-I-Mab Biopharma Co., Ltd. Revenue in Immuno-oncology Therapy Business (2018-2024)
11.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
11.17 Arcus Biosciences
11.17.1 Arcus Biosciences Company Details
11.17.2 Arcus Biosciences Business Overview
11.17.3 Arcus Biosciences Immuno-oncology Therapy Introduction
11.17.4 Arcus Biosciences Revenue in Immuno-oncology Therapy Business (2018-2024)
11.17.5 Arcus Biosciences Recent Developments
11.18 Gritstone Oncology
11.18.1 Gritstone Oncology Company Details
11.18.2 Gritstone Oncology Business Overview
11.18.3 Gritstone Oncology Immuno-oncology Therapy Introduction
11.18.4 Gritstone Oncology Revenue in Immuno-oncology Therapy Business (2018-2024)
11.18.5 Gritstone Oncology Recent Developments
11.19 Autolus Therapeutics
11.19.1 Autolus Therapeutics Company Details
11.19.2 Autolus Therapeutics Business Overview
11.19.3 Autolus Therapeutics Immuno-oncology Therapy Introduction
11.19.4 Autolus Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024)
11.19.5 Autolus Therapeutics Recent Developments
11.20 Rubius Therapeutics
11.20.1 Rubius Therapeutics Company Details
11.20.2 Rubius Therapeutics Business Overview
11.20.3 Rubius Therapeutics Immuno-oncology Therapy Introduction
11.20.4 Rubius Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024)
11.20.5 Rubius Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immuno-oncology Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immune Checkpoint Inhibitors
Table 4. Key Players of Immune System Modulators
Table 5. Key Players of Cancer Vaccines
Table 6. Global Immuno-oncology Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Immuno-oncology Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Immuno-oncology Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Immuno-oncology Therapy Market Share by Region (2018-2024)
Table 10. Global Immuno-oncology Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Immuno-oncology Therapy Market Share by Region (2024-2029)
Table 12. Immuno-oncology Therapy Market Trends
Table 13. Immuno-oncology Therapy Market Drivers
Table 14. Immuno-oncology Therapy Market Challenges
Table 15. Immuno-oncology Therapy Market Restraints
Table 16. Global Immuno-oncology Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Immuno-oncology Therapy Revenue Share by Players (2018-2024)
Table 18. Global Top Immuno-oncology Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
Table 19. Global Immuno-oncology Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Immuno-oncology Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Immuno-oncology Therapy, Headquarters and Area Served
Table 22. Global Key Players of Immuno-oncology Therapy, Product and Application
Table 23. Global Key Players of Immuno-oncology Therapy, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Immuno-oncology Therapy Revenue Market Share by Type (2018-2024)
Table 27. Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Immuno-oncology Therapy Revenue Market Share by Type (2024-2029)
Table 29. Global Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Immuno-oncology Therapy Revenue Share by Application (2018-2024)
Table 31. Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Immuno-oncology Therapy Revenue Share by Application (2024-2029)
Table 33. North America Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Immuno-oncology Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Immuno-oncology Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Immuno-oncology Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Immuno-oncology Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Immuno-oncology Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Immuno-oncology Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Immuno-oncology Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Immuno-oncology Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Immuno-oncology Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Immuno-oncology Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Immuno-oncology Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Immuno-oncology Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Immuno-oncology Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Immuno-oncology Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 65. Amgen Company Details
Table 66. Amgen Business Overview
Table 67. Amgen Immuno-oncology Therapy Product
Table 68. Amgen Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 69. Amgen Recent Developments
Table 70. AstraZeneca Company Details
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca Immuno-oncology Therapy Product
Table 73. AstraZeneca Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 74. AstraZeneca Recent Developments
Table 75. Bristol-Myers Squibb Company Details
Table 76. Bristol-Myers Squibb Business Overview
Table 77. Bristol-Myers Squibb Immuno-oncology Therapy Product
Table 78. Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. Eli-Lilly Company Details
Table 81. Eli-Lilly Business Overview
Table 82. Eli-Lilly Immuno-oncology Therapy Product
Table 83. Eli-Lilly Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 84. Eli-Lilly Recent Developments
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Immuno-oncology Therapy Product
Table 88. Roche Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 89. Roche Recent Developments
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Immuno-oncology Therapy Product
Table 93. GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 94. GlaxoSmithKline Recent Developments
Table 95. Janssen Biotech Company Details
Table 96. Janssen Biotech Business Overview
Table 97. Janssen Biotech Immuno-oncology Therapy Product
Table 98. Janssen Biotech Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 99. Janssen Biotech Recent Developments
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Immuno-oncology Therapy Product
Table 103. Merck Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 104. Merck Recent Developments
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Immuno-oncology Therapy Product
Table 108. Novartis Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 109. Novartis Recent Developments
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Immuno-oncology Therapy Product
Table 113. Pfizer Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 114. Pfizer Recent Developments
Table 115. Sanofi Company Details
Table 116. Sanofi Business Overview
Table 117. Sanofi Immuno-oncology Therapy Product
Table 118. Sanofi Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 119. Sanofi Recent Developments
Table 120. Spectrum Pharmaceuticals Company Details
Table 121. Spectrum Pharmaceuticals Business Overview
Table 122. Spectrum Pharmaceuticals Immuno-oncology Therapy Product
Table 123. Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 124. Spectrum Pharmaceuticals Recent Developments
Table 125. Takeda Company Details
Table 126. Takeda Business Overview
Table 127. Takeda Immuno-oncology Therapy Product
Table 128. Takeda Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 129. Takeda Recent Developments
Table 130. BioNTech SE Company Details
Table 131. BioNTech SE Business Overview
Table 132. BioNTech SE Immuno-oncology Therapy Product
Table 133. BioNTech SE Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 134. BioNTech SE Recent Developments
Table 135. Allogene Therapeutics Company Details
Table 136. Allogene Therapeutics Business Overview
Table 137. Allogene Therapeutics Immuno-oncology Therapy Product
Table 138. Allogene Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 139. Allogene Therapeutics Recent Developments
Table 140. IMAB-I-Mab Biopharma Co., Ltd. Company Details
Table 141. IMAB-I-Mab Biopharma Co., Ltd. Business Overview
Table 142. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product
Table 143. IMAB-I-Mab Biopharma Co., Ltd. Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 144. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
Table 145. Arcus Biosciences Company Details
Table 146. Arcus Biosciences Business Overview
Table 147. Arcus Biosciences Immuno-oncology Therapy Product
Table 148. Arcus Biosciences Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 149. Arcus Biosciences Recent Developments
Table 150. Gritstone Oncology Company Details
Table 151. Gritstone Oncology Business Overview
Table 152. Gritstone Oncology Immuno-oncology Therapy Product
Table 153. Gritstone Oncology Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 154. Gritstone Oncology Recent Developments
Table 155. Autolus Therapeutics Company Details
Table 156. Autolus Therapeutics Business Overview
Table 157. Autolus Therapeutics Immuno-oncology Therapy Product
Table 158. Autolus Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 159. Autolus Therapeutics Recent Developments
Table 160. Rubius Therapeutics Company Details
Table 161. Rubius Therapeutics Business Overview
Table 162. Rubius Therapeutics Immuno-oncology Therapy Product
Table 163. Rubius Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 164. Rubius Therapeutics Recent Developments
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-oncology Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Immuno-oncology Therapy Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Immune Checkpoint Inhibitors Features
Figure 5. Immune System Modulators Features
Figure 6. Cancer Vaccines Features
Figure 7. Global Immuno-oncology Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Immuno-oncology Therapy Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Center Case Studies
Figure 11. Others Case Studies
Figure 12. Immuno-oncology Therapy Report Years Considered
Figure 13. Global Immuno-oncology Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Immuno-oncology Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Immuno-oncology Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Immuno-oncology Therapy Market Share by Players in 2022
Figure 17. Global Top Immuno-oncology Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Immuno-oncology Therapy Revenue in 2022
Figure 19. North America Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Immuno-oncology Therapy Market Share by Type (2018-2029)
Figure 21. North America Immuno-oncology Therapy Market Share by Application (2018-2029)
Figure 22. North America Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 23. United States Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Immuno-oncology Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Immuno-oncology Therapy Market Share by Type (2018-2029)
Figure 27. Europe Immuno-oncology Therapy Market Share by Application (2018-2029)
Figure 28. Europe Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 29. Germany Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Immuno-oncology Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Immuno-oncology Therapy Market Share by Type (2018-2029)
Figure 37. China Immuno-oncology Therapy Market Share by Application (2018-2029)
Figure 38. Asia Immuno-oncology Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Immuno-oncology Therapy Market Share by Type (2018-2029)
Figure 40. Asia Immuno-oncology Therapy Market Share by Application (2018-2029)
Figure 41. Asia Immuno-oncology Therapy Market Share by Region (2018-2029)
Figure 42. Japan Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 52. Brazil Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Amgen Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 59. AstraZeneca Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 61. Eli-Lilly Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 62. Roche Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 64. Janssen Biotech Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 65. Merck Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 66. Novartis Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 67. Pfizer Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 68. Sanofi Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 69. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 70. Takeda Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 71. BioNTech SE Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 72. Allogene Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 73. IMAB-I-Mab Biopharma Co., Ltd. Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 74. Arcus Biosciences Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 75. Gritstone Oncology Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 76. Autolus Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 77. Rubius Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed